company background image
8279 logo

Syngen BiotechLtd TPEX:8279 Stock Report

Last Price

NT$131.00

Market Cap

NT$3.6b

7D

0.8%

1Y

-14.9%

Updated

24 Nov, 2024

Data

Company Financials

8279 Stock Overview

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. More details

8279 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Rewards

Risk Analysis

No risks detected for 8279 from our risk checks.

Syngen Biotech Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Syngen BiotechLtd
Historical stock prices
Current Share PriceNT$131.00
52 Week HighNT$163.50
52 Week LowNT$127.00
Beta0.43
11 Month Change-1.50%
3 Month Change-6.09%
1 Year Change-14.94%
33 Year Change23.00%
5 Year Change10.55%
Change since IPO1,228.11%

Recent News & Updates

Recent updates

Does Syngen BiotechLtd (GTSM:8279) Have A Healthy Balance Sheet?

Mar 25
Does Syngen BiotechLtd (GTSM:8279) Have A Healthy Balance Sheet?

Should Syngen Biotech Co., Ltd. (GTSM:8279) Be Part Of Your Dividend Portfolio?

Feb 25
Should Syngen Biotech Co., Ltd. (GTSM:8279) Be Part Of Your Dividend Portfolio?

Did You Miss Syngen Biotech's (GTSM:8279) Impressive 104% Share Price Gain?

Feb 04
Did You Miss Syngen Biotech's (GTSM:8279) Impressive 104% Share Price Gain?

Is Syngen Biotech Co., Ltd.'s (GTSM:8279) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 14
Is Syngen Biotech Co., Ltd.'s (GTSM:8279) Latest Stock Performance Being Led By Its Strong Fundamentals?

Syngen Biotech (GTSM:8279) Seems To Use Debt Quite Sensibly

Dec 16
Syngen Biotech (GTSM:8279) Seems To Use Debt Quite Sensibly

Syngen Biotech's (GTSM:8279) Earnings Are Growing But Is There More To The Story?

Nov 25
Syngen Biotech's (GTSM:8279) Earnings Are Growing But Is There More To The Story?

Shareholder Returns

8279TW PharmaceuticalsTW Market
7D0.8%1.4%0.8%
1Y-14.9%7.5%30.3%

Return vs Industry: 8279 underperformed the TW Pharmaceuticals industry which returned 7.5% over the past year.

Return vs Market: 8279 underperformed the TW Market which returned 30.3% over the past year.

Price Volatility

Is 8279's price volatile compared to industry and market?
8279 volatility
8279 Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement3.6%
Market Average Movement4.6%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 8279 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 8279's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988n/aWei Chenwww.syngen.com.tw

Syngen Biotech Co.,Ltd. engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. It also offers contract manufacturing; science-based and bio active pharmaceutical ingredients; and private labelling.

Syngen Biotech Co.,Ltd. Fundamentals Summary

How do Syngen BiotechLtd's earnings and revenue compare to its market cap?
8279 fundamental statistics
Market capNT$3.55b
Earnings (TTM)NT$238.77m
Revenue (TTM)NT$2.00b

14.9x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8279 income statement (TTM)
RevenueNT$2.00b
Cost of RevenueNT$1.29b
Gross ProfitNT$707.90m
Other ExpensesNT$469.13m
EarningsNT$238.77m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)8.81
Gross Margin35.39%
Net Profit Margin11.94%
Debt/Equity Ratio10.9%

How did 8279 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

57%

Payout Ratio